Botulinum toxin for the prevention and healing of wound scars: A systematic review of the literature

Background Botulinum toxin injections have been investigated for the treatment or prevention of hypertrophic scars in several clinical studies. However, its clinical effectiveness has not yet been established. Objective To examine all available evidence that support the use of botulinum toxin inject...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Plastic Surgery 2015-12, Vol.23 (4), p.260-264
Hauptverfasser: Prodromidou, Anastasia, Frountzas, Maximos, Vlachos, Dimitrios-Efthymios G, Vlachos, Georgios D, Bakoyiannis, Ioannis, Perrea, Despina, Pergialiotis, Vasilios
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 264
container_issue 4
container_start_page 260
container_title Plastic Surgery
container_volume 23
creator Prodromidou, Anastasia
Frountzas, Maximos
Vlachos, Dimitrios-Efthymios G
Vlachos, Georgios D
Bakoyiannis, Ioannis
Perrea, Despina
Pergialiotis, Vasilios
description Background Botulinum toxin injections have been investigated for the treatment or prevention of hypertrophic scars in several clinical studies. However, its clinical effectiveness has not yet been established. Objective To examine all available evidence that support the use of botulinum toxin injections for the treatment or prevention of hypertrophic scars in current clinical practice. Methods A systematic review searching the MEDLINE (1966 to 2014), Scopus (2004 to 2014), Popline (1974 to 2014), ClinicalTrials.gov (2008 to 2014) and Cochrane Central Register of Controlled Trials (CENTRAL) (1999 to 2014) databases together with reference lists from included studies was conducted. Results Te n studies (255 patients) were included. Of these, 123 patients were injected with botulinum toxin type A, nine patients were offered botulinum toxin type B and the remaining 123 patients represented the control groups. Significantly improved cosmetic outcomes were observed among certain studies using the visual analogue scale (experimental group: median score 8.25 [range 6 to 10]) versus control group: median score 6.38 [range 2 to 9]; P
doi_str_mv 10.1177/229255031502300402
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4664143</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1177_229255031502300402</sage_id><sourcerecordid>1749620281</sourcerecordid><originalsourceid>FETCH-LOGICAL-c442t-b846a0ccfe3c495d3985ae8e62a59481f16450d3189e97789ce9dc3c2ceb9b3b3</originalsourceid><addsrcrecordid>eNp9kU9rGzEQxUVpqYOTL5BD0TEXN_q_qxwKqUmTQiCX5iy02llbZnflStok_vaVcWpSAj3NMPq9p2EeQueUfKW0qi4Z00xKwqkkjBMiCPuATvbDhZSUfjz2hM_QWUobQggVkitRf0YzppSSVPAT1H4Peer9OA04hxc_4i5EnNeAtxGeYMw-jNiOLV6DLdQKhw4_h6kMkrMxXeFrnHYpw2Czd7hIPDzvmb1D7zNEm6cIp-hTZ_sEZ691jh5_3Pxa3i3uH25_Lq_vF04IlhdNLZQlznXAndCy5bqWFmpQzEotatpRJSRpOa016KqqtQPdOu6Yg0Y3vOFz9O3gu52aAVpX9o-2N9voBxt3Jlhv_n0Z_dqswpMRSolyjmJw8WoQw-8JUjaDTw763o4QpmRoJbRihNW0oOyAuhhSitAdv6HE7BMy7xMqoi9vFzxK_uZRgMsDkOwKzCZMcSwH-5_lH0z_mqk</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1749620281</pqid></control><display><type>article</type><title>Botulinum toxin for the prevention and healing of wound scars: A systematic review of the literature</title><source>SAGE Complete</source><source>PubMed Central</source><creator>Prodromidou, Anastasia ; Frountzas, Maximos ; Vlachos, Dimitrios-Efthymios G ; Vlachos, Georgios D ; Bakoyiannis, Ioannis ; Perrea, Despina ; Pergialiotis, Vasilios</creator><creatorcontrib>Prodromidou, Anastasia ; Frountzas, Maximos ; Vlachos, Dimitrios-Efthymios G ; Vlachos, Georgios D ; Bakoyiannis, Ioannis ; Perrea, Despina ; Pergialiotis, Vasilios</creatorcontrib><description>Background Botulinum toxin injections have been investigated for the treatment or prevention of hypertrophic scars in several clinical studies. However, its clinical effectiveness has not yet been established. Objective To examine all available evidence that support the use of botulinum toxin injections for the treatment or prevention of hypertrophic scars in current clinical practice. Methods A systematic review searching the MEDLINE (1966 to 2014), Scopus (2004 to 2014), Popline (1974 to 2014), ClinicalTrials.gov (2008 to 2014) and Cochrane Central Register of Controlled Trials (CENTRAL) (1999 to 2014) databases together with reference lists from included studies was conducted. Results Te n studies (255 patients) were included. Of these, 123 patients were injected with botulinum toxin type A, nine patients were offered botulinum toxin type B and the remaining 123 patients represented the control groups. Significantly improved cosmetic outcomes were observed among certain studies using the visual analogue scale (experimental group: median score 8.25 [range 6 to 10]) versus control group: median score 6.38 [range 2 to 9]; P&lt;0.001) and the Stony Brook Scar Evaluation Scale (experimental group score: 6.7 versus control group score: 4.17; P&lt;0.001) assessments. However, the methodological heterogeneity of the included studies, the lack of control group in the majority of them, the use of subjective scales of measurement and the frequent use of patient self-assessment precluded unbiased results. Conclusions Current evidence does not support the usage of botulinum toxin. Future randomized controlled trials are needed in the field to reach firm conclusions regarding its place in current clinical practice.</description><identifier>ISSN: 2292-5503</identifier><identifier>EISSN: 2292-5511</identifier><identifier>DOI: 10.1177/229255031502300402</identifier><identifier>PMID: 26665143</identifier><language>eng</language><publisher>Los Angeles, CA: SAGE Publications</publisher><subject>Review</subject><ispartof>Plastic Surgery, 2015-12, Vol.23 (4), p.260-264</ispartof><rights>2015 Plastic Surgery Journal Corporation</rights><rights>2015 Canadian Society of Plastic Surgeons. All rights reserved 2015</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c442t-b846a0ccfe3c495d3985ae8e62a59481f16450d3189e97789ce9dc3c2ceb9b3b3</citedby><cites>FETCH-LOGICAL-c442t-b846a0ccfe3c495d3985ae8e62a59481f16450d3189e97789ce9dc3c2ceb9b3b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4664143/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4664143/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,313,314,723,776,780,788,881,21798,27899,27901,27902,43597,43598,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26665143$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Prodromidou, Anastasia</creatorcontrib><creatorcontrib>Frountzas, Maximos</creatorcontrib><creatorcontrib>Vlachos, Dimitrios-Efthymios G</creatorcontrib><creatorcontrib>Vlachos, Georgios D</creatorcontrib><creatorcontrib>Bakoyiannis, Ioannis</creatorcontrib><creatorcontrib>Perrea, Despina</creatorcontrib><creatorcontrib>Pergialiotis, Vasilios</creatorcontrib><title>Botulinum toxin for the prevention and healing of wound scars: A systematic review of the literature</title><title>Plastic Surgery</title><addtitle>Plast Surg (Oakv)</addtitle><description>Background Botulinum toxin injections have been investigated for the treatment or prevention of hypertrophic scars in several clinical studies. However, its clinical effectiveness has not yet been established. Objective To examine all available evidence that support the use of botulinum toxin injections for the treatment or prevention of hypertrophic scars in current clinical practice. Methods A systematic review searching the MEDLINE (1966 to 2014), Scopus (2004 to 2014), Popline (1974 to 2014), ClinicalTrials.gov (2008 to 2014) and Cochrane Central Register of Controlled Trials (CENTRAL) (1999 to 2014) databases together with reference lists from included studies was conducted. Results Te n studies (255 patients) were included. Of these, 123 patients were injected with botulinum toxin type A, nine patients were offered botulinum toxin type B and the remaining 123 patients represented the control groups. Significantly improved cosmetic outcomes were observed among certain studies using the visual analogue scale (experimental group: median score 8.25 [range 6 to 10]) versus control group: median score 6.38 [range 2 to 9]; P&lt;0.001) and the Stony Brook Scar Evaluation Scale (experimental group score: 6.7 versus control group score: 4.17; P&lt;0.001) assessments. However, the methodological heterogeneity of the included studies, the lack of control group in the majority of them, the use of subjective scales of measurement and the frequent use of patient self-assessment precluded unbiased results. Conclusions Current evidence does not support the usage of botulinum toxin. Future randomized controlled trials are needed in the field to reach firm conclusions regarding its place in current clinical practice.</description><subject>Review</subject><issn>2292-5503</issn><issn>2292-5511</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><recordid>eNp9kU9rGzEQxUVpqYOTL5BD0TEXN_q_qxwKqUmTQiCX5iy02llbZnflStok_vaVcWpSAj3NMPq9p2EeQueUfKW0qi4Z00xKwqkkjBMiCPuATvbDhZSUfjz2hM_QWUobQggVkitRf0YzppSSVPAT1H4Peer9OA04hxc_4i5EnNeAtxGeYMw-jNiOLV6DLdQKhw4_h6kMkrMxXeFrnHYpw2Czd7hIPDzvmb1D7zNEm6cIp-hTZ_sEZ691jh5_3Pxa3i3uH25_Lq_vF04IlhdNLZQlznXAndCy5bqWFmpQzEotatpRJSRpOa016KqqtQPdOu6Yg0Y3vOFz9O3gu52aAVpX9o-2N9voBxt3Jlhv_n0Z_dqswpMRSolyjmJw8WoQw-8JUjaDTw763o4QpmRoJbRihNW0oOyAuhhSitAdv6HE7BMy7xMqoi9vFzxK_uZRgMsDkOwKzCZMcSwH-5_lH0z_mqk</recordid><startdate>20151201</startdate><enddate>20151201</enddate><creator>Prodromidou, Anastasia</creator><creator>Frountzas, Maximos</creator><creator>Vlachos, Dimitrios-Efthymios G</creator><creator>Vlachos, Georgios D</creator><creator>Bakoyiannis, Ioannis</creator><creator>Perrea, Despina</creator><creator>Pergialiotis, Vasilios</creator><general>SAGE Publications</general><general>Pulsus Group Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20151201</creationdate><title>Botulinum toxin for the prevention and healing of wound scars: A systematic review of the literature</title><author>Prodromidou, Anastasia ; Frountzas, Maximos ; Vlachos, Dimitrios-Efthymios G ; Vlachos, Georgios D ; Bakoyiannis, Ioannis ; Perrea, Despina ; Pergialiotis, Vasilios</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c442t-b846a0ccfe3c495d3985ae8e62a59481f16450d3189e97789ce9dc3c2ceb9b3b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Review</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Prodromidou, Anastasia</creatorcontrib><creatorcontrib>Frountzas, Maximos</creatorcontrib><creatorcontrib>Vlachos, Dimitrios-Efthymios G</creatorcontrib><creatorcontrib>Vlachos, Georgios D</creatorcontrib><creatorcontrib>Bakoyiannis, Ioannis</creatorcontrib><creatorcontrib>Perrea, Despina</creatorcontrib><creatorcontrib>Pergialiotis, Vasilios</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Plastic Surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Prodromidou, Anastasia</au><au>Frountzas, Maximos</au><au>Vlachos, Dimitrios-Efthymios G</au><au>Vlachos, Georgios D</au><au>Bakoyiannis, Ioannis</au><au>Perrea, Despina</au><au>Pergialiotis, Vasilios</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Botulinum toxin for the prevention and healing of wound scars: A systematic review of the literature</atitle><jtitle>Plastic Surgery</jtitle><addtitle>Plast Surg (Oakv)</addtitle><date>2015-12-01</date><risdate>2015</risdate><volume>23</volume><issue>4</issue><spage>260</spage><epage>264</epage><pages>260-264</pages><issn>2292-5503</issn><eissn>2292-5511</eissn><abstract>Background Botulinum toxin injections have been investigated for the treatment or prevention of hypertrophic scars in several clinical studies. However, its clinical effectiveness has not yet been established. Objective To examine all available evidence that support the use of botulinum toxin injections for the treatment or prevention of hypertrophic scars in current clinical practice. Methods A systematic review searching the MEDLINE (1966 to 2014), Scopus (2004 to 2014), Popline (1974 to 2014), ClinicalTrials.gov (2008 to 2014) and Cochrane Central Register of Controlled Trials (CENTRAL) (1999 to 2014) databases together with reference lists from included studies was conducted. Results Te n studies (255 patients) were included. Of these, 123 patients were injected with botulinum toxin type A, nine patients were offered botulinum toxin type B and the remaining 123 patients represented the control groups. Significantly improved cosmetic outcomes were observed among certain studies using the visual analogue scale (experimental group: median score 8.25 [range 6 to 10]) versus control group: median score 6.38 [range 2 to 9]; P&lt;0.001) and the Stony Brook Scar Evaluation Scale (experimental group score: 6.7 versus control group score: 4.17; P&lt;0.001) assessments. However, the methodological heterogeneity of the included studies, the lack of control group in the majority of them, the use of subjective scales of measurement and the frequent use of patient self-assessment precluded unbiased results. Conclusions Current evidence does not support the usage of botulinum toxin. Future randomized controlled trials are needed in the field to reach firm conclusions regarding its place in current clinical practice.</abstract><cop>Los Angeles, CA</cop><pub>SAGE Publications</pub><pmid>26665143</pmid><doi>10.1177/229255031502300402</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2292-5503
ispartof Plastic Surgery, 2015-12, Vol.23 (4), p.260-264
issn 2292-5503
2292-5511
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4664143
source SAGE Complete; PubMed Central
subjects Review
title Botulinum toxin for the prevention and healing of wound scars: A systematic review of the literature
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T00%3A42%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Botulinum%20toxin%20for%20the%20prevention%20and%20healing%20of%20wound%20scars:%20A%20systematic%20review%20of%20the%20literature&rft.jtitle=Plastic%20Surgery&rft.au=Prodromidou,%20Anastasia&rft.date=2015-12-01&rft.volume=23&rft.issue=4&rft.spage=260&rft.epage=264&rft.pages=260-264&rft.issn=2292-5503&rft.eissn=2292-5511&rft_id=info:doi/10.1177/229255031502300402&rft_dat=%3Cproquest_pubme%3E1749620281%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1749620281&rft_id=info:pmid/26665143&rft_sage_id=10.1177_229255031502300402&rfr_iscdi=true